- Home
- About Us
- Our Research
- Support Us
- Why support QIMR?
- Ways you can help us
- Donate Now
- Join the Rio Tinto Ride to Conquer Cancer
- Join our Regular Giving Club
- Join the Weekend to End Women's Cancers
- Leave a bequest in your will
- Purchase Christmas cards and hampers
- Corporate partnerships
- Workplace giving
- Fundraise for QIMR
- Attend a fundraising event
- Tribute gifts
- In memoriam gifts
- Stories of hope
- Book a tour or guest speaker
- Our supporters
- Thanks to our donors
- Students
- News & Events
- Careers
- Contact Us
- QSkin
- CMV study
- Queensland Pancreatic Cancer Study
- Australian Centre for Vaccine Development
| Tweet |
Group Leader
Associate Professor David Harrich
Summary
The Molecular Virology Laboratory analyses human immunodeficiency virus (HIV) replication. This includes the process by which HIV is able to convert its genetic material composed of RNA into a form compatible with human DNA. Our focus is the discovery of key viral or cellular molecules required for HIV to grow, and then to target their action so that HIV growth can be effectively blocked. The lab is also interested in cellular factors regulating respiratory syncytial virus (RSV) and Hendra virus replication.
Conditions researched
- HIV/AIDS
- Respiratory syncytial virus (RSV)
- Hendra virus
Current research
- Analysis of HIV host dependency factors required for early steps of HIV replication
- Regulation of HIV replication by RNA and ribonucleoprotein complexes
- Development of potent antiviral proteins based on the viral Tat protein
- Analysis of cellular proteins regulating HIV Rev protein function and trafficking in the cell
- Investigation of how cellular proteins facilitate replication of RSV and Hendra virus.
Staff
Group Leader: Associate Professor David Harrich
Postdoctoral staff: Dr Ann Apolloni, Dr Haran Sivakumaran, Dr Ting Wei, Dr Dongsheng Li
PhD students: Min-Hsuan Lin, Kylie Warren
Visiting scientists: Dr Kirsten Spann, Fangyun Qin, Rui Wang
Funding
We gratefully acknowledge the support of the following funding agencies:
- National Health and Medical Research Council
- Australian Research Council
- Australian Centre for HIV and Hepatitis Research
- Support from the Australian Centre for Infectious Diseases, QIMR and Australian Centre for HIV and Hepatitis (ACH2)
Collaborators
Professor Andreas Suhrbier, QIMR, Brisbane
Professor Richard Gaynor, Eli Lilly, Indianapolis
Professor David Jans, Monash University
Associate Professor Michael Kershaw,
Professor Hao Wu, Beijing Youan Hospital, P.R.China
Associate Professor Alun Jones, University of Queensland
Dr David Warrilow, Queensland Health Scientific Services




